Dr. Breyer presents data and subjective patient reports: Patients report a more „crisp“ vision in the Fine Vision TriumF eye when compared to classical trifocal Fine Vision IOL in the other eye.

1. Breyer, Kaymak & Klabe Eye Surgery and Premium Eyes are Consulting, Study Center & MAB for:
Abott, Alcon, AlimeraSciences, Allergan, AMO, Bayer, Carl Zeiss Meditec, Ellex, Fluoron, Geuder, iOptics, LensAR, Medicem,
Novartis, Oculentis, Oertli, Revision Optics, Santen, Staar Surgical,
Sifi Medtech, Thea, Topcon, Visufarma, Ziemer
First refractive outcomes and visual performance after implantation
of a new EDOF trifocal intraocular lens
Elke Taylor, D.R.H. Breyer, H. Kaymak, K. Klabe, M. Kirca
Breyer, Kaymak & Klabe Eye Surgery and Premium Eyes are Consulting, Study Center & MAB for:
Abott, Alcon, AlimeraSciences, Allergan, Alkahest, AMO, Bayer, Carl Zeiss Meditec, Ellex, Fluoron,
Gesundheitsamt Rhein-Neuss-Kreis, Geuder, Glaukos, Hangzhou Classon Tec, HOYA, iOptics,
KangHong Biotec., LensAR, Medicem, Novartis, Oculentis, Oertli, OMNITM, Optos, PharmaStulln,
PhysIOL, Revision Optics, Santen, Staar Surgical, Sifi Medtech, Teleon Surgical Optics, Thea, Topcon,
Visufarma, Ziemer

2. =>BALANCING LCA AT DISTANCE FOCI
Background: New Trifocal EDOF Patent Pending by PhysIOL, First Results

3. Monofocal IOL (mon, cc)
Triumf (mon, cc, n=17)
Reference curve Visus=1,0 (mon, sc)
0.00
0.25
0.50
0.75
1.00
1.25
-3.0
-2.5
-2.0
-1.5
-1.0
-0.5
0.0
Decimalvisus
Defocus [D]
Results: Defocus Curve: Fine Vision TriumF: DCVA
n = Number of eyes
mon = monocular
cc = distance corrected
100%
67%
43%
• Typical EDOF IOL
Defocus Curve
• No small print reading

4. PercentageofEyes[%]
0%
25%
50%
75%
100%
keine schwach mittel stark
Strength of Halo & Glare
none mild moderate severe
Strength of Halo & Glare
 Phakic Eyes (n=126)
 TriumF (n=14)
• Evaluation 1 week to
1 month post surgery
(new IOL)
• Improvement
expected by 3 months
due to neuroadaption
Results: Halo & Glare Simulator: Fine Vision TriumF - Phakic Eyes

5. Contrast Sensitivity: Fine Vision TriumF
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
1.5 3.0 6.0 12.0
Log10(CS)
Spatial frequency [cpd]
TriumF Glare (bin, cc, n=15)
TriumF NO Glare (bin, cc, n=14)
• Within usual limits
• Compareable to other diffractive MIOL
• Within usual limits
• Compareable to other diffractive MIOL
photopicmesopic
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
2.0
1.5 3.0 6.0 12.0
Log10(CS)
Spatial frequency [cpd]
TriumF Glare (bin, cc, n=14)
TriumF NO Glare (bin, cc, n=14)

6. Conclusion
• Visual Dynamics of new Fine Vision TriumF IOL close to other EDOF IOL
• No small print reading possible
• Photopic Phenomena: 3 months data needed for evaluation after neuroadaption
• Contrast sensitivity: very similar to other diffractive EDOF IOL
• Subjective patient reports: Patients report a more „crisp“ vision in the Fine Vision TriumF eye when
compared to classical trifocal Fine Vision IOL in the other eye
• 3 Months data needed and presented next year